Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1Phase 1 1

Status

Unknown 12Completed 9Recruiting 6Terminated 5Withdrawn 4Active not recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Prostatic Neoplasms 25Breast Neoplasms 21Glioblastoma 19Carcinoma, Non-Small-Cell Lung 17Sarcoma 11Lung Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Rectal Neoplasms 8Neoplasms 8Hodgkin Disease 8Head and Neck Neoplasms 8Brain Neoplasms 8Glioma 7Esophageal Squamous Cell Carcinoma 7Esophageal Neoplasms 7Uterine Cervical Neoplasms 6Pancreatic Neoplasms 6Oropharyngeal Neoplasms 6Astrocytoma 6Triple Negative Breast Neoplasms 5Melanoma 5Lymphoma 5Colorectal Neoplasms 5Neoplasm Metastasis 4Medulloblastoma 4Histiocytoma, Malignant Fibrous 4Carcinoma, Squamous Cell 4Small Cell Lung Carcinoma 3Rhabdomyosarcoma 3Recurrence 3

Interventions

durvalumab 18Bevacizumab 18atezolizumab 13lenvatinib 10Magnetic Resonance Spectroscopy 9tremelimumab 8Nivolumab 8pembrolizumab 7Sorafenib 6Specimen Handling 5camrelizumab 4cabozantinib 4Immunoglobulin G 4Disulfides 4apatinib 3X-Rays 3Radiotherapy 3Radiofrequency Ablation 3Radiation 3Hepatectomy 3E-7386 3Doxorubicin 3Cyclophosphamide 3tislelizumab 2sintilimab 2relatlimab 2dostarlimab 2budigalimab 2Standard of Care 2Simvastatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma, Hepatocellular × Radiotherapy × Clear all
NCT03186898 2026-05-07

Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer

NRG Oncology

Phase 3 Active not recruiting
186 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02626312 2026-04-30

Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
36 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT04857684 2025-10-01

SBRT + Atezolizumab + Bevacizumab in Resectable HCC

Massachusetts General Hospital

Phase EARLY_PHASE1 Active not recruiting
20 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡